Kopran
Kopran Performance
Day Range
- Low 258.10
- High 265.30
52 Week Range
- Low 96.00
- High 285.60
- Open Price260.00
- Previous Close258.05
- Volume331451
Start SIP in Kopran
Start SIPKopran Investment Rating
-
Master Rating:
-
Kopran has an operating revenue of Rs. 576.48 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of 7% is okay, ROE of 6% is fair but needs improvement. The company has a reasonable debt to equity of 4%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 12% and 44% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 2% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 64 which is a FAIR score but needs to improve its earnings, a RS Rating of 78 which is FAIR indicating the recent price performance, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 73 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock definitely has some strength, you may want to examine it in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 99 | 66 | 80 | 68 | 54 | 70 | 64 |
| Operating Expenses Qtr Cr | 90 | 64 | 73 | 62 | 48 | 64 | 58 |
| Operating Profit Qtr Cr | 9 | 2 | 7 | 6 | 6 | 6 | 7 |
| Depreciation Qtr Cr | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest Qtr Cr | 1 | 1 | 1 | 1 | 1 | 0 | 1 |
| Tax Qtr Cr | 2 | 0 | 2 | 1 | 1 | 1 | 2 |
| Net Profit Qtr Cr | 11 | 0 | 6 | 4 | 18 | 4 | 5 |
Kopran Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 14
- Bearish Moving Average
- ___
- 2
- 20 Day
- ₹249.20
- 50 Day
- ₹234.18
- 100 Day
- ₹217.13
- 200 Day
- ₹198.70
- 20 Day
- ₹247.61
- 50 Day
- ₹230.75
- 100 Day
- ₹214.43
- 200 Day
- ₹179.08
Kopran Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 263.57 |
| Second Resistance | 268.03 |
| Third Resistance | 270.77 |
| RSI | 62.81 |
| MFI | 76.47 |
| MACD Single Line | 9.97 |
| MACD | 10.19 |
| Support | |
|---|---|
| First Resistance | 256.37 |
| Second Resistance | 253.63 |
| Third Resistance | 249.17 |
Kopran Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 376,032 | 16,109,211 | 42.84 |
| Week | 399,038 | 15,829,828 | 39.67 |
| 1 Month | 923,221 | 32,063,452 | 34.73 |
| 6 Month | 698,736 | 26,454,162 | 37.86 |
Kopran Result Highlights
Kopran Synopsis
NSE-Medical-Diversified
Kopran Ltd is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 273.09 Cr. and Equity Capital is Rs. 48.21 Cr. for the Year ended 31/03/2023. Kopran Ltd. is a Public Limited Listed company incorporated on 26/04/1958 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1958PLC011078 and registration number is 011078.| Market Cap | 1,249 |
| Sales | 313 |
| Shares in Float | 2.70 |
| No of funds | 18 |
| Yield | 1.16 |
| Book Value | 3.16 |
| U/D Vol ratio | 1.1 |
| LTDebt / Equity | 1 |
| Alpha | 0.21 |
| Beta | 1.47 |
Kopran
| Owner Name | Sep-23 | Jun-23 | Mar-23 | Dec-22 |
|---|---|---|---|---|
| Promoters | 44.49% | 44.49% | 44.3% | 44.3% |
| Mutual Funds | 0.21% | |||
| Insurance Companies | 0.14% | 0.14% | 0.14% | 0.14% |
| Foreign Portfolio Investors | 0.39% | 0.34% | 0.41% | 0.34% |
| Financial Institutions/ Banks | ||||
| Individual Investors | 40.45% | 39.15% | 39.04% | 39.51% |
| Others | 14.32% | 15.88% | 16.11% | 15.71% |
Kopran Management
| Name | Designation |
|---|---|
| Mr. Susheel G Somani | Chairman |
| Mr. Surendra Somani | Executive Vice Chairman |
| Mr. Adarsh Somani | Director |
| Mr. Varun Somani | Director |
| Dr. Siddhan Subramanian | Independent Director |
| Dr. Sunita Banerji | Independent Director |
| Mrs. Mamta Biyani | Independent Director |
| Mr. Narayan Atal | Independent Director |
Kopran Forecast
Price Estimates
Kopran Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-11-07 | Quarterly Results | |
| 2023-08-10 | Quarterly Results | |
| 2023-05-25 | Audited Results & Dividend | |
| 2023-02-10 | Quarterly Results | |
| 2022-11-11 | Quarterly Results |
Kopran FAQs
What is Share Price of Kopran ?
Kopran share price is ₹259 As on 03 December, 2023 | 06:45
What is the Market Cap of Kopran ?
The Market Cap of Kopran is ₹1249.1 Cr As on 03 December, 2023 | 06:45
What is the P/E ratio of Kopran ?
The P/E ratio of Kopran is 39.6 As on 03 December, 2023 | 06:45
What is the PB ratio of Kopran ?
The PB ratio of Kopran is 2.8 As on 03 December, 2023 | 06:45